Omeros (OMER) Prices $30 Million Common Stock Offering at $10.25/Share

Omeros Corporation (NASDAQ: OMER) has priced an underwritten public offering of 2,926,830 shares of its common stock at a price to the public of $10.25 per share for gross proceeds of $30.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses, will be approximately $28.1 million.

Omeros intends to use the net proceeds of the offering for general corporate purposes, including expenses related to the clinical development of Omeros' two ongoing Phase 3 clinical development programs – OMS302 for use during intraocular lens replacement procedures and OMS103HP for use during arthroscopic partial meniscectomy surgery. The net offering proceeds may also be used to fund research and development in Omeros' preclinical studies and clinical trials, capital expenditures, working capital and to otherwise advance Omeros' product candidates toward commercialization.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tungray Technologies (TRSG) Prices 1.25M Share IPO at $4/sh
• Nutriband (NTRB) Announces 2.1M Share Offering at $4/sh
• Bio-Path Holdings (BPTH) Announces 375K Share Offering at $3.225/sh